(secondQuint)Clinical Performance of a Phakic Intraocular Lens (IOL).

 This is a prospective, open-labeled, multi-site evaluation of clinical performance of the STAAR EVO+ Visian cent Implantable Collamer(R) Lens (VICL) with Aspheric (EDOF) Optic [EDOF ICL] for the improvement of UCNVA in subjects who require between +1.

00 and +2.

50 Reading Add.

 Approximately 48 subjects who meet all eligibility criteria will undergo EDOF ICL implantation in both eyes.

 All eyes will be followed for 6 months after surgery.

 The first eye implanted with the study lens and the appropriate time for fellow eye implantation will be determined by the medical judgement of the Investigator.

 All eyes will be analyzed for safety and performance.

 The primary performance endpoint is defined as achievement of monocular UCNVA of Snellen equivalent 20/40 or better at 40 cm at 6 months after implantation in equal to or greater than 75% of implanted eyes.

.

 Clinical Performance of a Phakic Intraocular Lens (IOL)@highlight

This study will evaluate the clinical performance of a phakic intraocular lens (IOL) for the improvement of Uncorrected Near Visual Acuity (UCNVA) in subjects who require between +1.

00 and +2.

50 Reading Add.

